C. Hermans
Impact in
-
- Sarcoma Diagnosis and Treatment
- Oncology top 5%
- Vascular Tumors and Angiosarcomas
- CAR-T cell therapy research
Papers in
- Oncology 8
- Vascular Tumors and Angiosarcomas 8
-
- Sarcoma Diagnosis and Treatment 9
- Co-authors
- Ian Robert Judson (9 shared papers)Jean‐Yves Blay (7 shared papers)Jaap Verweij (7 shared papers)Pancras C.W. Hogendoorn (2 shared papers)Axel Le Cesne (4 shared papers)Martine Van Glabbeke (7 shared papers)Sandrine I. Marreaud (2 shared papers)Jeremy Whelan (1 shared paper)
- Journals
- European Journal of Cancer (6 papers)Anti-Cancer Drugs (1 paper)Journal of Quantitative Spectroscopy and Radiative Transfer (1 paper)Journal of Clinical Oncology (1 paper)The Lancet Oncology (1 paper)
- Partner nations
- United KingdomBelgiumNetherlands
In The Last Decade
C. Hermans
10 papers receiving 2.1k citations
C. Hermans's Hit Papers
Peers
Comparison fields: 5 of 89
- Pulmonary and Respiratory Medicine 1.3k
- Oncology 817
- Gastroenterology 129
- Cardiology and Cardiovascular Medicine 391
- Pathology and Forensic Medicine 208
Countries citing papers authored by C. Hermans
This map shows the geographic impact of C. Hermans's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C. Hermans with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C. Hermans more than expected).
Fields of papers citing papers by C. Hermans
This network shows the impact of papers produced by C. Hermans. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C. Hermans. The network helps show where C. Hermans may publish in the future.
Co-authors
The 25 scholars most cited alongside C. Hermans, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Doxorubicin alone versus intensified doxorubicin plus ifosfamide for first-line treatment of advanced or metastatic soft-tissue sarcoma: a randomised controlled phase 3 trial Hit paper breakdown → | 2014 | 928 |
| 2 | 2001 | 331 | |
| 3 | 2011 | 305 | |
| 4 | 2000 | 219 | |
| 5 | 2002 | 144 | |
| 6 | 2000 | 121 | |
| 7 | 2002 | 104 | |
| 8 | 1999 | 59 | |
| 9 | 1999 | 16 | |
| 10 | 2006 | 11 |
About C. Hermans
C. Hermans is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Pathology and Forensic Medicine, Gastroenterology and Surgery, having authored 10 papers that have together received 2.2k indexed citations. Recurring topics across this work include Sarcoma Diagnosis and Treatment (9 papers), Vascular Tumors and Angiosarcomas (8 papers), Renal and related cancers (2 papers), Lymphoma Diagnosis and Treatment (2 papers), Colorectal and Anal Carcinomas (2 papers), Advanced Chemical Physics Studies (1 paper), Spectroscopy and Laser Applications (1 paper) and Atmospheric Ozone and Climate (1 paper). The work is most often cited by research in Pulmonary and Respiratory Medicine (1.3k citations), Oncology (817 citations), Gastroenterology (129 citations), Cardiology and Cardiovascular Medicine (391 citations) and Pathology and Forensic Medicine (208 citations). C. Hermans has collaborated with scholars based in United Kingdom, Belgium and Netherlands. Frequent co-authors include Ian Robert Judson, Jean‐Yves Blay, Jaap Verweij, Pancras C.W. Hogendoorn, Axel Le Cesne, Martine Van Glabbeke, Sandrine I. Marreaud, Jeremy Whelan, Jan Martijn Kerst and Anders Krarup‐Hansen. Their work appears in journals such as European Journal of Cancer, Anti-Cancer Drugs, Journal of Quantitative Spectroscopy and Radiative Transfer, Journal of Clinical Oncology and The Lancet Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.